Vuong Trieu - 29 Jan 2025 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Issuer symbol
OTLC
Transactions as of
29 Jan 2025
Transactions value $
$9,712
Form type
4
Filing time
31 Jan 2025, 17:08:22 UTC
Previous filing
26 Nov 2024
Next filing
10 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $5.13K +183K +0.2% $0.03 93M 29 Jan 2025 Direct
transaction OTLC Common Stock Purchase $2.8K +100K +0.11% $0.03 93.1M 30 Jan 2025 Direct
transaction OTLC Common Stock Purchase $1.79K +63.8K +0.07% $0.03 93.2M 31 Jan 2025 Direct
holding OTLC Common Stock 16.8M 29 Jan 2025 By Autotelic, Inc.
holding OTLC Common Stock 6.87M 29 Jan 2025 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Between January 29, 2025 and January 31, 2025, Dr. Trieu purchased 346,844 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.028.